Institute For Neurodegenerative Disorders

Institute For Neurodegenerative Disorders logo
🇺🇸United States
Ownership
Private
Established
2001-01-01
Employees
101
Market Cap
-
Website
http://www.indd.org

Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-02
Last Posted Date
2017-01-06
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
19
Registration Number
NCT00970229
Locations
🇺🇸

Institute for Neurodegenerative Disorders, New haven, Connecticut, United States

Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition

Phase 1
Terminated
Conditions
First Posted Date
2009-08-28
Last Posted Date
2019-04-03
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
12
Registration Number
NCT00968097
Locations
🇺🇸

The Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2009-04-23
Last Posted Date
2019-04-03
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
2
Registration Number
NCT00886951
Locations
🇺🇸

Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

First Posted Date
2009-03-27
Last Posted Date
2017-01-06
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
48
Registration Number
NCT00870974
Locations
🇺🇸

Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2009-03-27
Last Posted Date
2019-04-03
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
2
Registration Number
NCT00870519
Locations
🇺🇸

Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition

First Posted Date
2008-04-14
Last Posted Date
2019-04-03
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
3
Registration Number
NCT00657813
Locations
🇺🇸

Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects

First Posted Date
2008-02-12
Last Posted Date
2019-04-03
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
46
Registration Number
NCT00612872
Locations
🇺🇸

Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2008-01-30
Last Posted Date
2010-10-06
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
3
Registration Number
NCT00605059
Locations
🇺🇸

Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

🇺🇸

Molecular NeuroImaging, LLC, New Haven, Connecticut, United States

Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2008-01-30
Last Posted Date
2010-10-06
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
1
Registration Number
NCT00605046
Locations
🇺🇸

Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

🇺🇸

Molecular NeuroImaging, LLC, New Haven, Connecticut, United States

Development of Cognitive Assessment Tools in Parkinson Disease

First Posted Date
2007-11-12
Last Posted Date
2012-02-09
Lead Sponsor
Institute for Neurodegenerative Disorders
Target Recruit Count
75
Registration Number
NCT00556764
Locations
🇺🇸

Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States

© Copyright 2024. All Rights Reserved by MedPath